This down-regulation was due to transcriptional or post-transcriptional deregulation, given that these cancers did not possess deep deletions or mutations in claudin genes, CLDN3, CLDN4 or CLDN7, and only 5% of claudin-low cases had deep deletions in the occludin gene OCLN. This evidence concerns the gene OCLN and cancer.